Clinical Trials in Baltimore

Showing 23421-23440 of 23,476 trials

A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea

NCT00000980

To determine the safety and effectiveness of intravenous spiramycin in patients with AIDS-related cryptosporidial diarrhea. Spiramycin, a macrolide antibiotic, has been studied in the United States for the treatment of cryptosporidial diarrhea. Some reports suggest that spiramycin is useful in improving the symptoms of cryptosporidial diarrhea in some patients. Results of one study, however, showed no significant difference between spiramycin and placebo (inactive medication). A later study indicated that the absorption of spiramycin is significantly decreased when food is present. Thus, the results of the trial may have been due to poor absorption of spiramycin.

CryptosporidiosisHIV Infections

Rhone-Poulenc Rorer25 participants

San Diego, California, United States • Baltimore, Maryland, United States • Worcester, Massachusetts, United States +4 more locations

UNKNOWNPhase 2/3< 1 mile

The Early Treatment for Retinopathy of Prematurity Study (ETROP)

NCT00027222

The goal of the Early Treatment for Retinopathy of Prematurity Study (ETROP) is to test the hypothesis that earlier treatment in carefully selected cases will result in an overall better visual outcome than treatment at the conventional CRYO-ROP threshold point in the disease.

Retinopathy of Prematurity

National Eye Institute (NEI)Started Oct 2001

Palo Alto, California, United States • San Francisco, California, United States • Chicago, Illinois, United States +23 more locations

A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea

The Early Treatment for Retinopathy of Prematurity Study (ETROP)

Find Trials by Condition in Baltimore

Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen

The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients

A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC

Multicenter Trial of Prednisone in Alzheimer's Disease

Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome

A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3

Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy

Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients

The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms

A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients

The Safety and Effectiveness of 935U83 in HIV-Infected Patients

Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.